The European Pharmaceutical Aerosol Group (EPAG), in collaboration with DDL, hosted the pre-DDL workshop on Wednesday 10th December 2025 at the Edinburgh International Conference Centre. The Workshop focussed on recent changes in regulatory, academia and science that impact OINDP products. It was a great opportunity for academia and industry to discuss the regulatory changes and their impact. It showcased how EPAG act as an advocacy group to steer efforts accordingly moving forward.
The three hour workshop was free to attend and attracted over 200 of the registered DDL delegates.
- Dr Tarlochan Singh Purewal presented an overview of EPAG providing a brief history, the vision, objectives, constitution, publications and information on how eligible companies can join EPAG.
- Three subgroups presented an overview of the purpose, achievements and on-going activities
- Hlack Mohammed – Impactor Subgroup
- Paul Kippax – Nasal Subgroup
- Mark Parry – Dissolution Subgroup
- There were two invited guest speakers
- Peter Caspers – as an individual expert. Peter works at the Dutch Medicines Evaluation Board. Peter gave an update on EMA Guidelines.
- Prof. Regina Scherließ – University of Kiel. Regina presented an overview of work EPAG has supported on Nasal Product Testing – now and in the future.
The workshop concluded with a Q&A panel discussion featuring the six presenters. Many of the presented materials are available on the EPAG website here (https://epag.co.uk/library/#27-258-wpfd-2025-pre-ddl-workshop)
